CervoMed Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CervoMed Inc. (CRVO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 356.35 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-07
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 57.05K shares, a 44.40% decline year-over-year.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 299.30K shares, a 9.71% increase year-over-year.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 91.20K shares, a 12.06% decline year-over-year.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 466.60K shares, a 50.03% increase from fiscal 2024.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 311.00K shares, a 56.59% increase from fiscal 2023.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 198.60K shares, a 157.63% increase from fiscal 2022.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 77.09K shares, a 112.31% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 57.05K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 356.35K shares 10-Q · filed 2026-08-07 | 447.55K shares derived: sum of 3 quarters · filed 2026-08-07 | 447.55K shares derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | 299.30K shares 10-Q · filed 2026-05-15 | 390.50K shares derived: sum of 2 quarters · filed 2026-05-15 | 390.50K shares derived: sum of 3 quarters · filed 2026-05-15 | 493.10K shares derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-12-31 | 91.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 91.20K shares derived: sum of 2 quarters · filed 2026-03-13 | 193.80K shares derived: sum of 3 quarters · filed 2026-03-13 | 466.60K shares 10-K · filed 2026-03-13 | ||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 102.60K shares derived: sum of 2 quarters · filed 2025-11-07 | 375.40K shares 10-Q · filed 2025-11-07 | 479.11K shares derived: sum of 4 quarters · filed 2025-11-07 | ||
| 2025-06-30 | 102.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 375.40K shares 10-Q · filed 2025-08-08 | 479.11K shares derived: sum of 3 quarters · filed 2025-08-08 | 479.11K shares derived: sum of 4 quarters · filed 2025-08-08 | ||
| 2025-03-31 | 272.80K shares 10-Q · filed 2025-05-12 | 376.51K shares derived: sum of 2 quarters · filed 2025-05-12 | 376.51K shares derived: sum of 3 quarters · filed 2025-05-12 | 413.86K shares derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2024-12-31 | 103.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | 103.71K shares derived: sum of 2 quarters · filed 2025-03-17 | 141.06K shares derived: sum of 3 quarters · filed 2025-03-17 | 311.00K shares 10-K · filed 2025-03-17 | ||
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 37.35K shares derived: sum of 2 quarters · filed 2024-11-12 | 207.28K shares 10-Q · filed 2024-11-12 | 353.31K shares derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2024-06-30 | 37.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 207.28K shares 10-Q · filed 2024-08-09 | 353.31K shares derived: sum of 3 quarters · filed 2024-08-09 | 405.88K shares derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2024-03-31 | 169.93K shares 10-Q · filed 2024-05-14 | 315.96K shares derived: sum of 2 quarters · filed 2024-05-14 | 368.53K shares derived: sum of 3 quarters · filed 2024-05-14 | 368.53K shares derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-12-31 | 146.03K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 198.60K shares derived: sum of 2 quarters · filed 2024-03-29 | 198.60K shares derived: sum of 3 quarters · filed 2024-08-09 | 198.60K shares 10-K · filed 2024-03-29 | ||
| 2023-09-30 | 52.57K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 52.57K shares derived: sum of 2 quarters · filed 2024-08-09 | 52.57K shares 10-Q · filed 2023-11-13 | 52.57K shares derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 0.00 shares 10-Q · filed 2024-08-09 | 0.00 shares derived: sum of 3 quarters · filed 2024-08-09 | 20.79K shares derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2024-05-14 | 20.79K shares derived: sum of 3 quarters · filed 2024-05-14 | |||
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | 20.79K shares derived: sum of 2 quarters · filed 2023-03-24 | 77.09K shares 10-K · filed 2023-03-24 | |||
| 2022-09-30 | 20.79K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 77.09K shares 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | 56.30K shares 10-Q · filed 2022-08-12 | |||||
| 2021-12-31 | -1.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | -887.80K shares derived: sum of 2 quarters · filed 2023-03-24 | -11.99K shares derived: sum of 3 quarters · filed 2023-03-24 | 36.31K shares 10-K · filed 2023-03-24 | 1.82M shares 10-K · filed 2022-03-18 | |
| 2021-09-30 | 808.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 1.68M shares derived: sum of 2 quarters · filed 2021-11-10 | 1.73M shares 10-Q · filed 2021-11-10 | 1.93M shares derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2021-06-30 | 875.82K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | 924.12K shares 10-Q · filed 2021-08-11 | 1.12M shares derived: sum of 3 quarters · filed 2022-05-12 | 1.74M shares derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2021-03-31 | 48.30K shares 10-Q · filed 2022-05-12 | 876.62K shares 10-Q · filed 2021-05-07 | 248.30K shares derived: sum of 2 quarters · filed 2022-05-12 | 860.70K shares derived: sum of 3 quarters · filed 2022-05-12 | 1.11M shares derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | 200.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | 812.40K shares derived: sum of 2 quarters · filed 2022-03-18 | 1.06M shares derived: sum of 3 quarters · filed 2022-03-18 | 1.93M shares 10-K · filed 2022-03-18 | ||
| 2020-09-30 | 612.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 857.60K shares derived: sum of 2 quarters · filed 2020-11-12 | 1.73M shares 10-Q · filed 2020-11-12 | 1.73M shares derived: sum of 4 quarters · filed 2021-03-17 | ||
| 2020-06-30 | 245.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | 1.12M shares 10-Q · filed 2020-08-07 | 1.12M shares derived: sum of 3 quarters · filed 2021-03-17 | 1.12M shares derived: sum of 4 quarters · filed 2021-03-17 | ||
| 2020-03-31 | 873.50K shares 10-Q · filed 2020-05-11 | 873.50K shares derived: sum of 2 quarters · filed 2021-03-17 | 873.50K shares derived: sum of 3 quarters · filed 2021-03-17 | 931.10K shares derived: sum of 4 quarters · filed 2021-03-17 | ||
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | 0.00 shares derived: sum of 2 quarters · filed 2021-03-17 | 57.60K shares derived: sum of 3 quarters · filed 2021-03-17 | 117.27K shares 10-K · filed 2021-03-17 | ||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | 57.60K shares derived: sum of 2 quarters · filed 2019-11-08 | 117.27K shares 10-Q · filed 2019-11-08 | -498.73K shares derived: sum of 4 quarters · filed 2020-03-17 | ||
| 2019-06-30 | 57.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 117.27K shares 10-Q · filed 2019-08-08 | -498.73K shares derived: sum of 3 quarters · filed 2020-03-17 | -498.73K shares derived: sum of 4 quarters · filed 2020-03-17 | ||
| 2019-03-31 | 59.67K shares 10-Q · filed 2019-05-09 | -556.33K shares derived: sum of 2 quarters · filed 2020-03-17 | -556.33K shares derived: sum of 3 quarters · filed 2020-03-17 | -396.32K shares derived: sum of 4 quarters · filed 2020-03-17 | ||
| 2018-12-31 | -616.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | -616.00K shares derived: sum of 2 quarters · filed 2020-03-17 | -456.00K shares derived: sum of 3 quarters · filed 2020-03-17 | 44.01K shares 10-K · filed 2020-03-17 | ||
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | 160.00K shares derived: sum of 2 quarters · filed 2018-11-13 | 660.00K shares 10-Q · filed 2018-11-13 | 343.30K shares derived: sum of 4 quarters · filed 2019-03-19 | ||
| 2018-06-30 | 160.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | 660.00K shares 10-Q · filed 2018-08-10 | 343.30K shares derived: sum of 3 quarters · filed 2019-03-19 | 363.30K shares derived: sum of 4 quarters · filed 2019-03-19 | ||
| 2018-03-31 | 500.00K shares 10-Q · filed 2018-05-10 | 183.30K shares derived: sum of 2 quarters · filed 2019-03-19 | 203.30K shares derived: sum of 3 quarters · filed 2019-03-19 | 425.16K shares derived: sum of 4 quarters · filed 2019-03-19 | ||
| 2017-12-31 | -316.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | -296.70K shares derived: sum of 2 quarters · filed 2019-03-19 | -74.84K shares derived: sum of 3 quarters · filed 2019-03-19 | 23.34K shares 10-K · filed 2019-03-19 | 350.04K shares 10-K · filed 2018-04-02 | |
| 2017-09-30 | 20.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | 241.86K shares derived: sum of 2 quarters · filed 2017-11-13 | 340.04K shares 10-Q · filed 2017-11-13 | 537.04K shares derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2017-06-30 | 221.86K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 320.04K shares 10-Q · filed 2017-08-14 | 517.04K shares derived: sum of 3 quarters · filed 2018-04-02 | 385.12K shares derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2017-03-31 | 98.18K shares 10-Q · filed 2017-05-15 | 295.18K shares derived: sum of 2 quarters · filed 2018-04-02 | 163.26K shares derived: sum of 3 quarters · filed 2018-04-02 | |||
| 2016-12-31 | 197.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | 65.08K shares derived: sum of 2 quarters · filed 2018-04-02 | 458.83K shares 10-K · filed 2018-04-02 | |||
| 2016-09-30 | -131.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 261.83K shares 10-Q · filed 2016-11-14 | ||||
| 2016-06-30 | 393.75K shares 10-Q · filed 2016-08-15 | |||||
| 2015-12-31 | 6.65K shares 10-K · filed 2016-03-25 | |||||
| 2014-12-31 | 3.29M shares 10-K · filed 2016-03-25 | |||||
| 2013-12-31 | 310.00K shares 10-K · filed 2015-04-03 | |||||
| 2012-12-31 | 0.00 shares derived: 10-Q/A 12 month − 10-Q 9 month · filed 2013-05-20 | 750.00K shares derived: sum of 2 quarters · filed 2013-05-20 | 3.05M shares 10-Q/A · filed 2013-05-20 | |||
| 2012-09-30 | 750.00K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | 3.05M shares 10-Q · filed 2012-11-19 | ||||
| 2012-06-30 | 2.30M shares 10-Q/A · filed 2012-09-07 | |||||
| 2011-12-31 | 5.01M shares 10-K/A · filed 2013-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |